A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease	Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Gaucher Disease, Type 1, Gaucher disease, Hemic and Lymphatic Diseases, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, anemia, brain disorder, central nervous system disorder, hematologic disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis	Recruiting	Phase 1 / Phase 2	2026-01-26		NCT06818838

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Lingyi Biotech Co., Ltd.	4

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guangzhou First People's Hospital	Guangzhou	China	5
Hematology Hospital, Chinese Academy of Medical Sciences	Tianjin	China	1
Shanxi Bethune Hospital	Taiyuan	China	23